Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-12-19

Clinical Trial Update: Etanercept and Vascular Function in Psoriasis [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the effect of etanercept on vascular function in patients with psoriasis has completed, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ENBREL (etanercept)

Snippet

Sponsor: Emory University | Conditions: PSORIASIS | Phase 2 | Status: COMPLETED | Results posted: 2014-12-19